Former Theranos scientist testifies to blood test inaccuracies prior to Walgreens deal in Elizabeth Holmes trial - Mass Device

A former Theranos scientist testified on the inaccuracies of the company's device during Elizabeth Holmes' federal fraud trial.

Surekha Gangakhedhar worked at Theranos from 2005 to 2013 and reported directly to Holmes at one point.

Gangakhedkar alleged that Holmes, in her opinion, was aware of the accuracy issues surrounding Theranos' Edison device. Holmes' defense attorneys filed an intent to object to Gangakhedkar's testimony on Thursday to block the scientist from testifying how much she thought Holmes knew about lab operations and Theranos' blood testing technology. Holmes claimed her company would revolutionize blood testing with technology that could analyze tiny amounts of blood and inked retail partnerships with Walgreens and Safeway. Forbes in 2015 recognized Holmes as America's richest self-made woman based on Theranos' multibillion-dollar valuation at the time. The downward spiral culminated in the 2018 shutdown of the company, with the U.S. Securities and Exchange Commission accusing Holmes and Balwani of what it described as a "Massive fraud."

Holmes faces 10 counts of wire fraud and two counts of conspiracy to commit wire fraud over allegations that she knowingly misled investors by claiming Theranos technology could revolutionize blood testing.


Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]